Carl A. Gregory

7.7k total citations · 2 hit papers
81 papers, 6.2k citations indexed

About

Carl A. Gregory is a scholar working on Genetics, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Carl A. Gregory has authored 81 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 29 papers in Molecular Biology and 25 papers in Biomedical Engineering. Recurrent topics in Carl A. Gregory's work include Mesenchymal stem cell research (35 papers), Tissue Engineering and Regenerative Medicine (14 papers) and Bone Tissue Engineering Materials (14 papers). Carl A. Gregory is often cited by papers focused on Mesenchymal stem cell research (35 papers), Tissue Engineering and Regenerative Medicine (14 papers) and Bone Tissue Engineering Materials (14 papers). Carl A. Gregory collaborates with scholars based in United States, United Kingdom and Germany. Carl A. Gregory's co-authors include Darwin J. Prockop, William Gunn, Jeffrey L. Spees, Alexandra Peister, Ryang Hwa Lee, Harpreet Singh, Joni Ylöstalo, U. Krause, Anthony S. Perry and Adam Conley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Carl A. Gregory

79 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction

2004 1.3k citations Carl A. Gregory, William Gunn et al. profile →
Mechanisms of mesenchymal stem/stromal cell function

2016 657 citations Ryang Hwa Lee, Carl A. Gregory et al. Stem Cell Research & Therapy profile →

Peers

Countries citing papers authored by Carl A. Gregory

Since Specialization

Citations

This map shows the geographic impact of Carl A. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl A. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl A. Gregory more than expected).

Fields of papers citing papers by Carl A. Gregory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl A. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl A. Gregory. The network helps show where Carl A. Gregory may publish in the future.

Co-authorship network of co-authors of Carl A. Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of Carl A. Gregory. A scholar is included among the top collaborators of Carl A. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl A. Gregory. Carl A. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fabrication and application of salicin-polycaprolactone 3D-printed scaffold in the healing of femur bone defects 2024 ·Biomedical Materials ·(unknown), (unknown), Mohammad Nabiuni, Homa Mohseni Kouchesfahani, Latifeh Karimzadeh, Carl A. Gregory	4
2	Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost 2024 ·Cytotherapy ·(unknown), (unknown), Robert E. Rogers, (unknown), (unknown), (unknown), Daniela A. Oliveira, (unknown), (unknown), (unknown), (unknown), Eun‐Hye Bae, Yu Zhang, Kristen C. Maitland, Z̆ivko L. Nikolov, Fei Liu, Ryang Hwa Lee, Roland Kaunas, Carl A. Gregory	2
3	The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction 2024 ·Frontiers in Molecular Biosciences ·Carl A. Gregory, (unknown), (unknown)	2
4	Factors affecting the role of canonical Wnt inhibitor Dickkopf-1 in cancer progression 2023 ·Frontiers in Oncology ·(unknown), (unknown), Donald F. Turner, Carl A. Gregory	2
5	Canine Mesenchymal Stromal Cell-Mediated Bone Regeneration is Enhanced in the Presence of Sub-Therapeutic Concentrations of BMP-2 in a Murine Calvarial Defect Model 2021 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Suzanne Zeitouni, Eoin P. McNeill, (unknown), Carl A. Gregory, W. Brian Saunders	0
6	Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilities 2020 ·Nature Communications ·Eoin P. McNeill, Suzanne Zeitouni, (unknown), (unknown), (unknown), (unknown), Bret H. Clough, U. Krause, (unknown), Mayra García, (unknown), Qingguo Zhao, W. Brian Saunders, Fei Liu, Roland Kaunas, Carl A. Gregory	40
7	Optimizing In Vitro Osteogenesis in Canine Autologous and Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells with Dexamethasone and BMP-2 2020 ·Stem Cells and Development ·(unknown), (unknown), Lyndah Chow, Steven Dow, Carl A. Gregory, W. Brian Saunders	10
8	Interplay between degradability and integrin signaling on mesenchymal stem cell function within poly(ethylene glycol) based microporous annealed particle hydrogels 2019 ·Acta Biomaterialia ·Shangjing Xin, Carl A. Gregory, Daniel L. Alge	42
9	Creating Physicochemical Gradients in Modular Microporous Annealed Particle Hydrogels via a Microfluidic Method 2019 ·Advanced Functional Materials ·Shangjing Xin, Jing Dai, Carl A. Gregory, Arum Han, Daniel L. Alge	57
10	In vitro MSC function is related to clinical reaction in vivo 2018 ·Stem Cell Research & Therapy ·(unknown), Jiajie Xu, (unknown), Carl A. Gregory, Douglas F. Antczak, Kevin J. Cummings, Ashlee E. Watts	11
11	In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study 2017 ·Stem Cell Research & Therapy ·(unknown), (unknown), Kevin J. Cummings, Roger K. Smith, Carl A. Gregory, W. Brian Saunders	62
12	Scalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It 2016 ·PLoS ONE ·Dong Ki Kim, Hosoon Choi, Hidetaka Nishida, Joo Youn Oh, Carl A. Gregory, Ryang Hwa Lee, Ji Min Yu, Jun Watanabe, Su Yeon An, Thomas J. Bartosh, Darwin J. Prockop	21
13	A Simple Critical-sized Femoral Defect Model in Mice 2015 ·Journal of Visualized Experiments ·Bret H. Clough, (unknown), Carl A. Gregory	14
14	Sox11 Is Expressed in Early Progenitor Human Multipotent Stromal Cells and Decreases with Extensive Expansion of the Cells 2010 ·Tissue Engineering Part A ·Benjamin L. Larson, Joni Ylöstalo, (unknown), Carl A. Gregory, Darwin J. Prockop	58
15	The CD34-like protein PODXL and α6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice 2008 ·Blood ·Ryang Hwa Lee, Min Jeong Seo, А. А Пулин, Carl A. Gregory, Joni Ylöstalo, Darwin J. Prockop	154
16	A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies 2007 ·British Journal of Cancer ·(unknown), (unknown), Scott D. Olson, David Olmos, Jakob Reiser, Robert Kutner, Najat C. Daw, Darwin J. Prockop, Edwin M. Horwitz, Carl A. Gregory	63
17	The Promise of Canonical Wnt Signaling Modulators in Enhancing Bone Repair 2006 ·Drug News & Perspectives ·Carl A. Gregory, Angela Green, Narae Lee, (unknown), William Gunn	18
18	The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone Marrow 2003 ·Journal of Biological Chemistry ·Carl A. Gregory, Harpreet Singh, Anthony S. Perry, Darwin J. Prockop	234
19	Metaphyseal Chondrodysplasia Type Schmid Mutations Are Predicted to Occur in Two Distinct Three-dimensional Clusters within Type X Collagen NC1 Domains That Retain the Ability to Trimerize 1999 ·Journal of Biological Chemistry ·Debora S. Marks, Carl A. Gregory, Gillian A. Wallis, Andy Brass, Karl E. Kadler, Ray Boot-Handford	31
20	Procedure to calculate the explosion frequency for a module of an offshore platform 1994 ·Process Safety and Environmental Protection ·John Andrews, R. S. Smith, Carl A. Gregory	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact